Novo Nordisk's European shares fell 7% as the Trump administration abandoned its proposal to cover weight loss drugs with Medicare
2025-04-07 15:04:52

Novo Nordisk's European shares fell 7% after the Trump administration abandoned a proposal to cover weight loss drugs with Medicare.
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.
ASIA TECH WIRE

Grasp technology trends

Download